SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-004806
Filing Date
2024-04-08
Accepted
2024-04-08 09:25:43
Documents
117
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F rdhl-20231231x20f.htm   iXBRL 20-F 3633956
2 EX-1.1 rdhl-20231231xex1d1.htm EX-1.1 294312
3 EX-2.3 rdhl-20231231xex2d3.htm EX-2.3 86081
4 EX-12.1 rdhl-20231231xex12d1.htm EX-12.1 13415
5 EX-12.2 rdhl-20231231xex12d2.htm EX-12.2 16249
6 EX-13 rdhl-20231231xex13.htm EX-13 9795
7 EX-15.1 rdhl-20231231xex15d1.htm EX-15.1 5342
8 EX-97.1 rdhl-20231231xex97d1.htm EX-97.1 46602
9 GRAPHIC rdhl-20231231x20f008.jpg GRAPHIC 3984
10 GRAPHIC rdhl-20231231xex15d1001.jpg GRAPHIC 4382
  Complete submission text file 0001558370-24-004806.txt   12722870

Data Files

Seq Description Document Type Size
11 EX-101.SCH rdhl-20231231.xsd EX-101.SCH 101872
12 EX-101.CAL rdhl-20231231_cal.xml EX-101.CAL 59140
13 EX-101.DEF rdhl-20231231_def.xml EX-101.DEF 294828
14 EX-101.LAB rdhl-20231231_lab.xml EX-101.LAB 650964
15 EX-101.PRE rdhl-20231231_pre.xml EX-101.PRE 502266
121 EXTRACTED XBRL INSTANCE DOCUMENT rdhl-20231231x20f_htm.xml XML 2208784
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 24828327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)